Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jaya Agra Wattie Tbk (JAWA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Jaya Agra Wattie TbkTrade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Jaya Agra Wattie Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Jaya Agra Wattie Tbk trades at Rp148 (market cap 2.69T, 16.53M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jaya Agra Wattie Tbk is far larger — about 25.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

JAWASCPI
Market Cap
2.69T104.4B
Volume
16.53M
Lot
165.29K
Turnover
2.51B
Average Price
151.99
Value
2.51B
Indicative Equilibrium Price
148
Indicative Equilibrium Volume
6.3K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JAWA
View details
SCPI
View details

About Jaya Agra Wattie Tbk

PT Jaya Agra Wattie was founded with the name Handel Maatschappij J.A. Wattie and Company Limited. PT Jaya Agra Wattie (Persero) is one of private agribusiness corporations engaging in plantation, processing and agricultural logistics and marketing activities. Having 90 years of experience in the agriculture sector, the company continually strengthens its business base through a diversification approach by cultivating various premium plantations of primary raw commodities such as rubber, crude palm oil (CPO), coffee and tea.

Read more on JAWA

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI